D. M. Ponomarenko, D. Yukalchuk, S. S. Sidorova, Yulia A Chapygina
{"title":"非小细胞晚期肺癌的一线双重免疫治疗","authors":"D. M. Ponomarenko, D. Yukalchuk, S. S. Sidorova, Yulia A Chapygina","doi":"10.33978/2307-3586-2022-18-13-24-28","DOIUrl":null,"url":null,"abstract":"Using an example from clinical practice, the issues of treatment of advanced non-small cell lung cancer in the absence of activating mutations are considered.","PeriodicalId":11400,"journal":{"name":"Effective Pharmacotherapy","volume":"51 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"First-Line Double Immunotherapy for Non-Small Cell Advanced Lung Cancer\",\"authors\":\"D. M. Ponomarenko, D. Yukalchuk, S. S. Sidorova, Yulia A Chapygina\",\"doi\":\"10.33978/2307-3586-2022-18-13-24-28\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Using an example from clinical practice, the issues of treatment of advanced non-small cell lung cancer in the absence of activating mutations are considered.\",\"PeriodicalId\":11400,\"journal\":{\"name\":\"Effective Pharmacotherapy\",\"volume\":\"51 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-04-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Effective Pharmacotherapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33978/2307-3586-2022-18-13-24-28\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Effective Pharmacotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33978/2307-3586-2022-18-13-24-28","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
First-Line Double Immunotherapy for Non-Small Cell Advanced Lung Cancer
Using an example from clinical practice, the issues of treatment of advanced non-small cell lung cancer in the absence of activating mutations are considered.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
